GlaxoSmithKline (GSK) and the University of North Carolina at Chapel Hill (UNC) are launching Qura Therapeutics, which will focus on finding a cure for HIV/AIDS. The companies announced today that they are jointly launching a research center that will focus on one of the areas of most intense interest in …